anti-SMT3 Suppressor of Mif Two 3 Homolog 4 (S. Cerevisiae) (SUMO4) Anticorps

SUMO4 is a member of the SUMO gene family. De plus, nous expédions SUMO4 Protéines (3) et beaucoup plus de produits pour cette protéine.

afficher tous les anticorps Gène GeneID UniProt
SUMO4 387082 Q6EEV6
SUMO4    
SUMO4    
Comment commander chez anticorps-enligne
  • +1 877 302 8632
  • +1 888 205 9894 (toll-free)
  • Commandez enligne
  • orders@anticorps-enligne.fr

Top anti-SUMO4 Anticorps sur anticorps-enligne.fr

Showing 10 out of 93 products:

Catalogue No. Reactivité Hôte Conjugué Application Images Quantité Livraison Prix Détails
Humain Lapin Inconjugué EIA, IHC (p), WB 0.4 mL 6 to 8 Days
$484.00
Détails
Humain Lapin Inconjugué EIA, IHC (p), WB 0.4 mL 6 to 8 Days
$484.00
Détails
Humain Lapin Inconjugué EIA, IHC (p), WB 0.4 mL 6 to 8 Days
$484.00
Détails
Humain Lapin Inconjugué IHC, WB Western blot analysis of extracts of various cell lines, using SUMO4 antibody (ABIN5971586) at 1:800 dilution. Immunohistochemistry of paraffin-embedded human kidney cancer using SUMO4 Antibody (ABIN5971586) at dilution of 1/200 (40x lens). 100 μL 11 to 16 Days
$426.40
Détails
Humain Lapin Inconjugué IHC, WB Western blot analysis of SUMO4 expression in Jurkat (A), MCF7 (B) whole cell lysates. 200 μL 13 to 14 Days
$487.50
Détails
Humain Lapin Inconjugué ELISA, IHC, WB Western blot analysis of Hepg2 whole cell lysates, using SUMO4  Antibody. The lane on the left is treated with the antigen-specific peptide. ABIN6277441 at 1/100 staining Rat brain tissue by IHC-P. The sample was formaldehyde fixed and a heat mediated antigen retrieval step in citrate buffer was performed. The sample was then blocked and incubated with the antibody for 1.5 hours at 22¡ãC. An HRP conjugated goat anti-rabbit antibody was used as the secondary 100 μL 11 to 12 Days
$390.77
Détails
Humain Lapin Inconjugué IHC (p), WB Western blot analysis of SUMO4 Antibody (M55 Wild type) in HepG2 cell line lysate (35ug/lane). Formalin-fixed and paraffin-embedded human hepatocarcinoma tissue reacted with SUMO4 antibody (M55 Wild type) , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. 400 μL 2 to 3 Days
$515.63
Détails
Humain Lapin Inconjugué IHC, WB 100 μL 11 to 13 Days
$366.77
Détails
Humain Lapin Inconjugué IHC (p), WB Western blot analysis of SUMO4 Antibody (V55 Mutant) in HepG2 cell line lysate (35ug/lane). Formalin-fixed and paraffin-embedded human hepatocarcinoma tissue reacted with SUMO4 antibody (V55 Mutant) , which was peroxidase-conjugated to the secondary antibody, followed by DAB staining. 400 μL 2 to 3 Days
$515.63
Détails
Humain Souris Inconjugué IF, WB Western Blot analysis of SUMO4 expression in transfected 293T cell line by SUMO4 MaxPab polyclonal antibody.Lane 1: SUMO4 transfected lysate(10.45 KDa).Lane 2: Non-transfected lysate. Immunofluorescence of purified MaxPab antibody to SUMO4 on HeLa cell. [antibody concentration 10 ug/ml] 50 μL 11 to 12 Days
$440.00
Détails

anti-SUMO4 Anticorps mieux référencés

  1. Human Polyclonal SUMO4 Primary Antibody pour IHC (p), ELISA - ABIN543391 : Bohren, Nadkarni, Song, Gabbay, Owerbach: A M55V polymorphism in a novel SUMO gene (SUMO-4) differentially activates heat shock transcription factors and is associated with susceptibility to type I diabetes mellitus. dans The Journal of biological chemistry 2004 (PubMed)
    Show all 3 Pubmed References

  2. Human Polyclonal SUMO4 Primary Antibody pour IHC (p), ELISA - ABIN543392 : Guo, Li, Zhang, Yang, Eckenrode, Hopkins, Zheng, Purohit, Podolsky, Muir, Wang, Dong, Brusko, Atkinson, Pozzilli, Zeidler, Raffel, Jacob, Park, Serrano-Rios, Larrad, Zhang, Garchon, Bach, Rotter, She et al.: A functional variant of SUMO4, a new I kappa B alpha modifier, is associated with type 1 diabetes. ... dans Nature genetics 2004 (PubMed)
    Show all 3 Pubmed References

  3. Human Polyclonal SUMO4 Primary Antibody pour IHC (p), ELISA - ABIN543390 : Park, Park, Kang, Yang, Kim: Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. dans Nature genetics 2005 (PubMed)
    Show all 3 Pubmed References

Plus d’anticorps contre SUMO4 partenaires d’interaction

Human SMT3 Suppressor of Mif Two 3 Homolog 4 (S. Cerevisiae) (SUMO4) interaction partners

  1. Donor SUMO4 rs237025 genetic variant was associated with higher tacrolimus C/D ratios in the early period after liver transplantation, which might be related to the down-regulation of CYP3A5 enzyme through the NF-kB signalling pathway.

  2. meta-analysis demonstrated that the G allele of the SUMO4 M55V polymorphism could be a susceptible risk locus to type 2 diabetes mellitus, mainly in the Chinese population, while the association in other ethnic population needs to be further validated

  3. Both donor and recipient SUMO4 rs237025 polymorphisms contribute to the development of new-onset diabetes mellitus after liver transplantation.

  4. Results show that SUMO-4 is expressed in normal placental development. SUMO-4 expression was increased in pre-eclamptic placentas and in models of oxidative stress and hypoxic injury suggesting that SUMO-4 hyper-SUMOylation may be a potential post-translational mechanism in the stressed pre-eclamptic placenta.

  5. study suggests that SUMO4 c.163 G to A polymorphism is associated with the susceptibility to diabetic nephropathy in north Indian subjects with type 2 diabetes

  6. SUMO4 M55V polymorphism and type-2 diabetes were significantly associated with a possible SUMO4 region to type-2 diabetes susceptibility.

  7. No association between SUMO4 gene polymorphisms and acoronary artery disease with and without type 2 diabetes mellitus.

  8. SUMO4 Met55Val variant was associated with increased insulin resistance in Chinese patients with newly diagnosed type 2 diabetes.

  9. study demonstrates significant associations of SUMO4 M55V polymorphism with type 1 diabetes mellitus in Asian and Caucasian population and with type 2 diabetes mellitus in Asian population

  10. The C438T polymorphism in the SUMO4 gene is associated with significantly increased risk of papulopustular skin lesions in HLA-B51-positive Behcet's disease patients.

  11. This meta-analysis indicates that the SUMO4 M55V polymorphism confers susceptibility to type I diabetes in Asians and Europeans.

  12. the association between small ubiquitin-like modifier 4 (SUMO4) gene polymorphisms and type 2 diabetes mellitus

  13. Letter: report SUMO4 polymorphisms associated with protective effect in Tunisian rheumatoid arthritis patients.

  14. The SUMO4 gene single nucleotide polymorphism variant is not associated with susceptibility of the type 2 diabetes polymorphism.

  15. SUMO4 gene polymorphisms may be involved in the development of skin lesions, vascular Behcet's disease, as well as the severity of the disease.

  16. SUMO4 gene M55V variant is associated with the genetic susceptibility of type 1 diabetes mellitus (T1D) in Chinese children.

  17. This study suggests that in Taiwan the SUMO4 Met 55Val polymorphism is associated with susceptibility to T2DM and Type 2 diabetic patients with GG genotype have worse glycemic control.

  18. total of 2317 families were genotyped for 15 SNPs in the SUMO4 region.

  19. we report evidence for an association between T1D and multiple single-nucleotide polymorphisms in 197 kb of genomic DNA in the IDDM5 interval.

  20. SUMO4 sumoylation may play an important role in the regulation of intracellular stress

SUMO4 profil antigène

Profil protéine

This gene is a member of the SUMO gene family. This family of genes encode small ubiquitin-related modifiers that are attached to proteins and control the target proteins' subcellular localization, stability, or activity. The protein described in this record is located in the cytoplasm and specifically modifies IKBA, leading to negative regulation of NF-kappa-B-dependent transcription of the IL12B gene. A specific polymorphism in this SUMO gene, which leads to the M55V substitution, has been associated with type I diabetes. The RefSeq contains this polymorphism.

Gene names and symbols associated with SUMO4

  • small ubiquitin-like modifier 4 (SUMO4) anticorps
  • small ubiquitin-related modifier 4 (sumo4) anticorps
  • SMT3 suppressor of mif two 3 homolog 4 (S. cerevisiae) (SUMO4) anticorps
  • dJ281H8.4 anticorps
  • IDDM5 anticorps
  • SMT3H4 anticorps
  • SUMO-4 anticorps

Protein level used designations for SUMO4

SMT3 suppressor of mif two 3 homolog 4 (S. cerevisiae) , small ubiquitin-related modifier 4 , SMT3 suppressor of mif two 3 homolog 2 , SMT3 suppressor of mif two 3 homolog 4 , small ubiquitin-like modifier 4 protein , SUMO-4

GENE ID SPECIES
748349 Pan troglodytes
100335145 Oryzias latipes
387082 Homo sapiens
100127140 Sus scrofa
Fournisseurs de qualité sélectionnés pour anti-SUMO4 (SUMO4) Anticorps
Avez-vous cherché autre chose?